Name: | Li Hong |
Post: | Attending |
Position: | Director |
Education: | Master |
Professional: | Endocrinology & Metabolism |
Departments: | The Affiliated Sir Run Run Shaw Hospital |
Research: | Dibetes and its complications;Metabolic Syndrome |
TEL: | |
E-mail: | lihongheyi@126.com |
Personal Home Page: | |
Profile
SOCIETY MEMBERSHIPS:
Member of Standing Committee, Endocrinologist and metabolic Diseases Physician Society of Chinese Medical Doctor Association
Member of Committee, Endocrinology Society of Chinese Medical Association
Member of Committee, Chinese Diabetes Society
Candidate Chairman,Zhejiang Endocrinology Society
Member of Editorial Board: Chinese Journal of Endocrinology & Metabolism, Chinese Journal of Diabetes, Chinese Journal of Practical Internal Medicine, Journal of Zhejiang University (Medical Sciences)
EDUCATION AND PROFESSIONAL EXPERIENCE
Professor Li graduated from Zhejiang University School of Medicine (formerly Zhejiang Medical University) in 1982 and worked in the First Affiliated Hospital of Zhejiang University School of Medicine after graduation. She received her Master degree of Endocrine and Metabolic Diseases from Zhejiang University School of Medicine in 1989. She transferred to Sir Run Run Shaw Hospital, Zhejiang University School of Medicine in Nov. 2006. Li has received trainings at Harvard University Joslin Diabetes Center in the United States (Mar. 2003) and was a visiting scholar/visiting professor at Luebeck Medical University in Germany (1991-1992) as well as several universities in the United States, including Loma Linda University (Mar. 2007),Mayo Clinic (July 2007), MD Anderson Cancer Center (April-June 2008) and Johns Hopkins University School of Medicine (Mar. 2008),. Li was elected master instructor in 1996, and elected PhD supervisor in 2004. She has trained 40 graduate students and 6 Ph.D. students.
EXPERTISE AND RESEARCH INTERESTS
Endocrine Metabolic disease science (clinical, teaching and research), mainly pathogenesis, early diagnosis and treatment of diabetes and its chronic complications; basic and clinical research of metabolic syndrome.
CURRENT RESEARCH PROJECTS
1. Diagnostic Criteria for Metabolic Syndrome. Eleventh "Five-Year" National Science and Technology Support Program (sub-Project PI)
2. Establishment of Community Management Network and Screening for Susceptibility Genes of Diabetic Nephropathy. Zhejiang Province Bureau of Science and Technology's Major Project (PI)
Has completed several National Natural Science Foundation project and Zhejiang Provincial Natural Science Foundation projects ( PI).
PUBLICATIONS: more than 70 published articles, including 13 SCI journal articles. The major articles since recent four years:
1. Zheng F, Lu W, Hu X, Wu F, Hu X, Zhang F, Li Hong. Recombinant Decorin Ameliorates the Pulmonary Structure Alterations by Down-regulating Transforming Growth Factor-β1/Smads Signaling in the Diabetic Rats. Endocr Res 35:35-49, 2010
2. Fengping Zheng, Weina Lu, Chengfang Jia, Hong Li, Zhou Wang, Weiping Jia.
Relationships between glucose excursion and the activation of oxidative stress in patients with newly diagnosed type 2 diabetes or impaired glucose regulation. Endocr 37:201–208, 2010
3. Zhe Zhang, Fang Wu, Fengping Zheng, Hong Li. Adenovirus-mediated decorin gene transfection has therapeutic effects in a streptozocin-induced diabetic rat model. Nephron Exp Nephrol 114, 2010
4. Goldhaber-Fiebert JD,Li H, Ratanawijitrasin S, Vidyasagar S, Wang XY, Aljunid S, Shah N, Wang Z, Hirunrassamee S, Bairy KL, Wang J, Saperi S, Nur AM, Eggleston K. Inpatient treatment of diabetic patients in Asia: evidence from India, China, Thailand and Malaysia. Diabet Med 27(1):101-8, 2010
5. JianZhou, Hong Li, Xingwu Ran, Wenying Yang, Qiang Li, Yongde Peng, Yanbing Li, Xin Gao, Xiaojun Luan, Weiqing Wang, Weiping Jia. Reference Values for Continuous Glucose Monitoring in Chinese Subjects. Diabetes Care 32:1188–1193, 2009
6. F. Wu, H. Yao, A. Bader, F. Dong, F. Zhu, N. Wu, B. Wang, H.Li, N.H. Brockmeyer, P. Altmeyer. Decorin gene transfer inhibited the expression of TGFβ1 and ECM in rat mesangial cells. Eur J Med Res 12:360-368, 2007
7. Lu Weina,Li Hong,Zheng Fenping,Huang Hong,Ruan Yu. Risk factors of renal function deficiency in type 2 diabetic patients with normal albuminuria. Chinese Journal of Internal Medicine 49:24-27,2010
8. Huang Hong, Li Hong, Zheng Fenping,Lu Weina,Dong Xuehong,Ruan Yu. The Clinical Features and Risk factors of Renal Damage in Elderly and Non-elderly Patients with Type 2 Diabetes Mellitus National Medical Journal of China 90: ?2010
9. Zheng Fengpin,Wang Zhou,Li Hong, Jia Chengfang,Zhang Nan,Yuan Hongdi. Correlation between the amplitude of glucose excursion and plasma 8-iso prostaglandin F2α level in subjects with different types of glucose regulation National Medical Journal of China 89:3-7,2009
10. He Fei,Li Hong,Li Wansheng,Dong Xuehong. The expression and clinical significance of muc1 and β-catenin in papillary thyroid carcinoma National Medical Journal of China 89:393-399,2009
11. Dong Fenqin,Li Hong,Wu Fang,Yao Hangping. Effects of overexpression of decorin on matrix metalloproteinases 2 and 9 in rat mesangial and tubular cells National Medical Journal of China 88:3444-3447,2008
12. Zhu Feng,Li Hong,Wu Fang,Yang Zhenggang. Effect of recombinant adenovirus vector of decorin on the expression of extracellular matrix molecules in rat mesangial cells Chinese Journal of Pathophysiology 23:1791-1795,2007
13. Ye Xun,Li Hong,Zhang Jinhong,Zhao Xiaoxia. Phenotypic conversion of renal cortex cells in streptozotocin-induced diabetic rats Chinese Journal of Pathophysiology 23:1645-1647,2007
14. Zhang Min,Li Hong,Zhang Zhe. Clinical characteristics of early-onset type 2 diabetes and risk factors associated with its chronic complications. National Medical Journal of China 86:2547-2550,2006
15. Chen Sanmei, Li Hong, Wang Fang, Chen Xiaofei, Li Xusheng,Chen Guorong. Effects of gingko biloba extract on the renal structure and function in type 2 diabetic rats. Chinese Journal of Pathophysiology 22:1654-1656,2006
RESEARCH AWARDS
1.Relationship of nitric oxide and diabetic nephropathy. Awarded the third prize of Advances in Science & Technology by Zhejiang Provincial Government (2002, PI)
2.The investigation of renal protective effect and mechanisms of pioglitazone on diabetic kidneys. Awarded the third prize of Advances in Science & Technology by Zhejiang Provincial Government (2003, PI)
3.Effect of Decorin on diabetic nephropathy. Awarded the third prize of Advances in Science & Technology by Zhejiang Provincial Government ( 2008, PI)
PUBLISHED BOOK CHAPTERS:
1.Diabetes: Prevention, Treatment and Care. Hangzhou Press (1999,Editor)
2.Osteoporosis. Rural Readings Press (2000,Editor)
3.Advances in Internal Medicine. Zhejiang University Press(2000,2008, Co-author).
4.Handbook of Clinical Drug Therapy. People's Health Press (2002, Co-author)
5.Endocrinology & Metabolism Syndromes. Liaoning People's Press & Liaoning Science and Technology Press (2002, Co-author)
6.Clinical Therapy in General Medical Practice Science Press (2002, Co-author)
7.China Guideline for Type 2 Diabetes. (2007, Member of the the Committee)
8.China Clinical Guideline for Continuous Glucose Monitoring. (2009, Member of the Committee)
9.China Clinical Guideline for Insulin Pump Therapy (2009, Member of the Committee)